David Kerstein
Officer at Theseus Pharmaceuticals, Inc. (THRX)
David Kerstein has filed 3 insider reports with the SEC since February 2022, as officer at Theseus Pharmaceuticals, Inc. (THRX). The latest filing, on March 2, 2023, reports grant or award at Theseus Pharmaceuticals, Inc. (THRX).
- Filings
- 3
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where David Kerstein is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer | Mar 2, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 1, 2023THRXSEC Form 4 filed by Kerstein DavidForm 4Grant or award
- Feb 17, 2023THRXSEC Form 4 filed by Kerstein DavidForm 4Grant or award
- Feb 18, 2022THRXSEC Form 4 filed by Kerstein DavidForm 4Grant or award
Compare David Kerstein with
- David Kerstein vs Kathy Yi1 shared
- David Kerstein vs Steven H Stein1 shared
- David Kerstein vs Donald J Hayden Jr1 shared
- David Kerstein vs Carl L Gordon1 shared
- David Kerstein vs Iain D. Dukes1 shared
- David Kerstein vs Bradford D. Dahms1 shared
Questions about David Kerstein
- What is David Kerstein's role at Theseus Pharmaceuticals, Inc.?
- David Kerstein reports to the SEC as officer at Theseus Pharmaceuticals, Inc. (THRX), according to the latest filing on March 2, 2023.
- Has David Kerstein bought or sold stock recently?
- No open-market purchases or sales by David Kerstein are on file. The filings report grant or award.
- How do I get alerts when David Kerstein files?
- Follow David Kerstein on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by David Kerstein (SEC CIK 0001796388). Totals count each trade once, skipping amendments whose original is on file, from Feb 24, 2022 on. View on SEC EDGAR · Get this as JSON